Publications by authors named "Andrew R Rezvani"

33Publications

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20 B Cell Malignancies.

Biol Blood Marrow Transplant 2020 Oct 18;26(10):1811-1818. Epub 2020 Jul 18.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.07.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549403PMC
October 2020

Costs and Outcomes with Once-Daily versus Every-6-Hour Intravenous Busulfan in Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2020 01 13;26(1):145-149. Epub 2019 Sep 13.

Stanford Hospital and Clinics, Stanford, California; Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.008DOI Listing
January 2020

Incidence of Active Tuberculosis After Hematopoietic Cell Transplantation: A Small but Real Threat.

Clin Infect Dis 2020 Mar;70(6):1261-1262

Divisions of Infectious Diseases & Geographic Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz592DOI Listing
March 2020

Acute Graft-versus-Host Disease.

Authors:
Andrew R Rezvani

N Engl J Med 2018 02;378(6):585-586

Stanford University, Stanford, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1716969DOI Listing
February 2018

A new standard for HIV-associated lymphoma.

Authors:
Andrew R Rezvani

Blood 2016 08;128(8):1026-7

STANFORD UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-06-723890DOI Listing
August 2016

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.

Biol Blood Marrow Transplant 2015 Feb 1;21(2):281-7. Epub 2014 Nov 1.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408880PMC
February 2015

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2015 Jan 30;21(1):105-12. Epub 2014 Sep 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Division of Oncology, University of Washington, School of Medicine, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140060
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.09.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286386PMC
January 2015

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes.

Curr Opin Hematol 2013 Nov;20(6):509-14

Transplantation Biology Program, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328365a151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112741PMC
November 2013

Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.

Biol Blood Marrow Transplant 2013 Jul 10;19(7):1033-9. Epub 2013 Apr 10.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898851PMC
July 2013

Prevention of graft-vs.-host disease.

Expert Opin Pharmacother 2012 Aug 7;13(12):1737-50. Epub 2012 Jul 7.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2012.703652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509175PMC
August 2012

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2011 Nov 30;17(11):1594-601. Epub 2011 Jul 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center and University of Washington Medical Center, 1100Fairview Ave. N, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203323PMC
November 2011

Rituximab resistance.

Best Pract Res Clin Haematol 2011 Jun 13;24(2):203-16. Epub 2011 Apr 13.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2011.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113665PMC
June 2011

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2008 Dec;14(12):1380-4

Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810860PMC
December 2008

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation.

J Autoimmun 2008 May 31;30(3):172-9. Epub 2008 Jan 31.

Transplantation Biology Program, Fred Hutchinson Cancer Research Center and University of Washington, 1100 Fairview Ave N, MS D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2007.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329571PMC
May 2008

Using allogeneic stem cell/T-cell grafts to cure hematologic malignancies.

Expert Opin Biol Ther 2008 Feb;8(2):161-79

Senior Fellow Fred Hutchinson Cancer Research Center & University of Washington, Transplantation Biology, Clinical Research Division, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.8.2.161DOI Listing
February 2008